Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Sanofi shelves four assets, including mid-stage dwarfism candidate
10 months ago
R&D
AbbVie expects $8.7B Cerevel buy to close ‘as early as next week,’ new CEO says
10 months ago
R&D
Sanofi eyes RSV antibody for its next blockbuster while Dupixent brings in record sales
10 months ago
Manufacturing
Roche cuts two more TIGIT trials, plans accelerated timeline for obesity drugs
10 months ago
R&D
Updated: AstraZeneca says there’s ‘very limited’ impact on Farxiga after US drug pricing negotiations
10 months ago
BioMarin snags expanded Brineura label, now approved for all kids regardless of symptoms
10 months ago
FDA+
Argenx to retest Vyvgart in autoimmune platelet disease after failure last year
10 months ago
R&D
Republican-led states can't intervene in case on abortion pill restrictions, appeals court says
10 months ago
Law
US bankrolls a third of global Pandemic Fund. Can it get congressional support?
10 months ago
Coronavirus
Activist investor calls for board shakeup at Assertio, threatens proxy contest
10 months ago
PBM executives dodge grilling in House committee hearing
10 months ago
Law
FDA asks adcomm if AstraZeneca needs another study on Imfinzi before and after lung cancer surgery
10 months ago
FDA+
AbbVie files lawsuit in Missouri federal court over 340B contract pharmacies
10 months ago
Law
Updated: Merck, without sharing details, says RSV antibody successfully protected infants
10 months ago
R&D
Pfizer lifts curtain on $740M+ extension at API manufacturing site in Singapore
10 months ago
Manufacturing
The obesity drug race is being fought on the manufacturing floor as GLP-1 rivals make plans to catch leaders
10 months ago
In Focus
Manufacturing
Bluebird bio handed negative opinion from federal oversight agency for fertility support program
10 months ago
FDA+
Law
Updated: Samsung wins FDA approval for second Soliris biosimilar
10 months ago
FDA+
North Carolina's Medicaid program to cover weight loss drugs beginning in August
10 months ago
China approves Eli Lilly's weight loss drug as country launches obesity awareness campaign
10 months ago
China
Vermont attorney general sues two major PBMs for allegedly driving up costs
10 months ago
US inks $113M deal with Siga to bolster smallpox, mpox reserves
10 months ago
European Commission president’s second-term pledge: simpler regulations, better funding and tackling shortages
10 months ago
Roivant recently sold one spinout for billions. Is Priovant next?
10 months ago
Deals
R&D
First page
Previous page
45
46
47
48
49
50
51
Next page
Last page